MedTrace Logo

Microbiome and Papillary Thyroid Microcarcinoma

NCT04376203 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-06-30

No results posted yet for this study

Summary

It has been shown that gut microbiome and microbiome metabolism can regulate or control the initiation of a cancer process. To the best of the investigators knowledge, no study has directly shown the relationship of the thyroid microcarcinoma to the human microbiome. In this work, the aim is to detect the microbiome in peripheral blood in a patient with a thyroid gland carcinoma, and to correlate it with the disease, compared to the microbiome of a group of patients who did not find another thyroid gland carcinoma

Conditions

  • Papillary Thyroid Microcarcinoma
  • Microbiome

Interventions

PROCEDURE

Thyroidectomy

Typical Thyroidectomy

Sponsors & Collaborators

  • University of Ioannina

    lead OTHER

Principal Investigators

  • KONSTANTINOS VLACHOS, Associate Professor of Surgery · University of Ioannina

  • IOANNIS KOUTELIDAKIS, Associate Professor of Surgery · Aristotle University Of Thessaloniki

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-27
Primary Completion
2022-05-30
Completion
2023-05-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04376203 on ClinicalTrials.gov